Review: taking Meclizine and Claritin d together


Summary

Drug interactions are reported among people who take Meclizine and Claritin d together. This review analyzes the effectiveness and drug interactions between Meclizine and Claritin d. It is created by eHealthMe based on reports of 364 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Meclizine and Claritin d >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Meclizine

Meclizine has active ingredients of meclizine. It is often used in dizziness. (latest outcomes from Meclizine 5,735 users)

Claritin D

Claritin d has active ingredients of loratadine. It is often used in multiple allergies. (latest outcomes from Claritin d 33 users)

On Jul, 20, 2016

364 people who take Meclizine, Claritin D are studied.


Number of reports submitted per year:

Meclizine and Claritin d drug interactions.

Drug effectiveness over time:

Meclizine:
  • < 1 month: 0.0% - (0 of 4 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 2 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 100.0% - (2 of 2 people)
Claritin D:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 100.0% - (2 of 2 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 33.0% - (1 of 3 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Meclizine:
  • female: 28.0% - (2 of 7 people)
  • male: 0.0% - (0 of 1 people)
Claritin D:
  • female: 66.0% - (4 of 6 people)
  • male: 0.0% - (0 of 2 people)

Drug effectiveness by age:

Meclizine:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 0.0% - (0 of 3 people)
  • 60+: 100.0% - (2 of 2 people)
Claritin D:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 100.0% - (3 of 3 people)
  • 50-59: 0.0% - (0 of 3 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • vision blurred
  • agitation
  • anxiety
  • breath odour
  • burning sensation
  • constipation
  • dizziness
  • long-term memory loss
  • nausea
  • night sweats
1 - 2 years:
  • dizziness
  • long-term memory loss
  • nausea
  • vision blurred
2 - 5 years:
  • depression
  • gerd
  • high blood cholesterol
  • high blood pressure
  • migraine
  • ms
  • thyroiditis
  • vertigo
  • anxiety
  • cognitive disorder
5 - 10 years:
  • arthralgia
  • osteoporosis
  • biopsy breast abnormal
  • breast cancer
  • breast necrosis
  • dyspnoea
  • fibrocystic breast disease
  • mammogram abnormal
  • musculoskeletal pain
  • nasal septum deviation
10+ years:
  • myocardial infarction
not specified:
  • dizziness
  • dyspnoea
  • asthenia
  • anxiety
  • chest pain
  • nausea
  • headache
  • pain
  • fatigue
  • anaemia

Most common drug interactions by gender *:

female:
  • dizziness
  • urinary tract infection
  • dyspnoea
  • anxiety
  • asthenia
  • headache
  • chest pain
  • nausea
  • anaemia
  • pain
male:
  • dyspnoea
  • fatigue
  • chest pain
  • asthenia
  • pain in extremity
  • nausea
  • pain
  • anxiety
  • dizziness
  • headache

Most common drug interactions by age *:

0-1:
  • anxiety
  • asthma
  • blood cholesterol increased
  • bronchitis
  • fungal infection
  • gallbladder operation
  • pyrexia
  • sensation of foreign body
  • stomatitis
  • type 2 diabetes mellitus
10-19:
  • cholecystitis chronic
  • gallbladder disorder
20-29:
  • cerebrovascular accident
  • convulsion
  • fear
  • anxiety
  • cerebral thrombosis
  • cerebral venous thrombosis
  • cognitive disorder
  • dizziness
  • ecchymosis
  • haemorrhagic transformation stroke
30-39:
  • deep vein thrombosis
  • pulmonary embolism
  • palpitations
  • injury
  • chest pain
  • dyspepsia
  • dyspnoea
  • fatigue
  • injection site inflammation
  • nausea
40-49:
  • dizziness
  • dyspnoea
  • dehydration
  • nausea
  • anaemia
  • oropharyngeal pain
  • asthenia
  • chest pain
  • headache
  • arthralgia
50-59:
  • dizziness
  • anxiety
  • fatigue
  • asthenia
  • dyspnoea
  • hyperhidrosis
  • palpitations
  • chest pain
  • nausea
  • pain
60+:
  • dizziness
  • anaemia
  • asthenia
  • chest pain
  • urinary tract infection
  • dyspnoea
  • pain
  • cataract
  • anxiety
  • oedema peripheral

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Meclizine and Claritin d?

Can you answer these questions?

More questions for: Meclizine, Claritin d

You may be interested in these reviews

More reviews for: Meclizine, Claritin d

On eHealthMe, Meclizine (meclizine) is often used to treat dizziness. Claritin d (loratadine) is often used to treat multiple allergies. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.